Efimosfermin alfa

DB28564InvestigationalProtein Based Therapies

Efimosfermin Alfa is a biologic drug. Efimosfermin Alfa is under investigation in clinical trial NCT07221188 (A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants...

Mechanism: Pharmacologically active on Fibroblast growth factor receptor 1 and Beta-klotho
Curator reviewed
Also known as: Efimosfermin
Code names: BOS-580 · LLF-580

Resolves to

Compound

UNIIY114QW0F16CAS2765640-39-7

Targets

P11362FGFR1Q86Z14KLB

What you can answer from here — as of July 01, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Efimosfermin alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account